Pune, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Global Insulin Market size is expected to gain momentum owing to the high prevalence of diabetes during the forecast period. This information is published in this latest report, titled, “Global Insulin Market, 2022-2028.” Insulin controls the body's fat and glucose metabolism. It is a peptide hormone that is secreted by beta cells in the islets of Langerhans in the pancreas and aids in glucose metabolism regulation. It promotes glucose to be absorbed from the blood by skeletal muscle cells and fat tissues. The rising prevalence of diabetes, changes in lifestyles, an increase in the obese and geriatric population, and insufficient healthcare resources are all factors that contribute to the growing number of diabetic patients globally. Favorable government policies and technological advancements, such as the development of Insulin pens, have also contributed to the Insulin market growth.
List of Key Players Profiled in the Global Market for Insulin:
- Novo Nordisk
- Eli Lilly
- Sanofi-Aventis
- Tonghua Dongbao
- Ganlee
- United Laboratory
- Jiangsu Wanbang
Get a Sample PDF of report @
https://proficientmarketinsights.com/enquiry/request-sample/19924580?utm_source=GV
COVID-19 Impact-
COVID-19 is expected to fuel the growth of diabetes cases, and as the pathophysiology of COVID-19-induced diabetes is better understood, there will be more patients in need of targeted therapeutics.
COVID-19 may induce T1D by destroying Insulin-producing cells in the pancreas, either directly or due to inflammation caused by the immune system battling the virus. The SARS-CoV-2 virus may thrive in high-blood-glucose environments, which could lead to T2D (transient Insulin deficit).
Segment by Type
- Animal Insulin
- Regular Human Insulin
- Insulin Analogue
Segment by Application
- Short Acting
- Intermediate Acting
- Long Acting
- Pre-Mix Insulin
Have a query before purchasing this report –
https://proficientmarketinsights.com/enquiry/pre-order-enquiry/19924580?utm_source=GV
North America is expected to hold the largest Global Insulin Market share during the forecast period. Because of the high prevalence of diabetes in the region due to a sedentary lifestyle, particularly the U.S., dominates the global market. The cost aspect is a key concern in the U.S., where the country generates over half of the Insulin revenues for the makers. The majority of diabetic drug manufacturers regard the country as a key market for increasing overall global sales.
The global market is highly consolidated, with three major manufacturers having a global presence and the remaining manufacturers focusing on local or regional markets. Mergers and acquisitions that have occurred recently between the participants have helped the corporations enhance their market presence.
In April 2019, Eli Lilly and Company announced the launch of Insulin Lispro, a generic version of analogue Humalog Insulin. Humalog is more accessible to diabetes patients in the country because of its lower prices. In the near future, this category is projected to drive the human Insulin market.
Buy this report (Price 4900 USD for a single-user license) –
https://proficientmarketinsights.com/purchase/19924580?utm_source=GV
Detailed TOC of Global Insulin Market:
1 Study Coverage
1.1 Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Animal Insulin
1.2.3 Regular Human Insulin
1.2.4 Insulin Analogue
1.3 Market by Application
1.3.1 Global Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Sales by Region
2.4.1 Global Insulin Sales by Region (2017-2022)
2.4.2 Global Sales Insulin by Region (2023-2028)
2.5 Global Insulin Revenue by Region
2.5.1 Global Insulin Revenue by Region (2017-2022)
2.5.2 Global Insulin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
About Us:
Proficient Market Insights is the credible source for gaining the market reports that will provide you with the lead your business needs. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.
